TRICARE Pharmacy Program RFI
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm) contract. This Request For Information (RFI) is the method for initiating market research efforts as the Government begins to build requirements and documentation related to this program.
Disclaimer:
This announcement does not constitute a commitment, implied or otherwise that a solicitation or contract will be issued. Issuance of the RFI is for planning purposes only and does not commit the Government to any contractual agreements or arrangements. The Government is not soliciting proposals with this request.
Please note that the collection of the requested information does not obligate the Government to incorporate solicited comments or procure any services. Responses to this announcement will not be returned. The Government is not liable to pay any costs associated with companies responding to this announcement.
Issuance of the RFI is intended to provide interested parties with information on the anticipated procurement and provide an opportunity for industry feedback into the preliminary programmatic design. All information received resulting from this RFI will be used by the DHA as market research. However, responses may be releasable to the public under the Freedom of Information Act (FOIA) unless appropriately marked.
The DHA, at its discretion, may request respondents to elaborate on information in their written response in writing or through other means. Respondents will not be notified of any results derived from a review of the information provided.
Any responses from the Government are subject to change, as the requirements themselves remain in draft form. Interested parties will have opportunity to seek clarification from the Government for any remaining questions, particularly those pertaining to evaluation criteria, incentives, or contract requirements, at the final RFP stage.
All responses must be provided via email to dha.buckley.ad-spt-cae.mbx.tpharm6@health.mil by January 30, 2026 12:00 pm MST.